nach oben

Seminars in Immunopathology

Erschienen in:

27.02.2024 | Review

Epithelial recognition and elimination against aberrant cells

verfasst von: Shiyu Ayukawa, Nagisa Kamoshita, Takeshi Maruyama

Erschienen in: Seminars in Immunopathology | Ausgabe 4-6/2024

Einloggen, um Zugang zu erhalten

Abstract

Epithelial cells, which are non-immune cells, not only function as a physical defence barrier but also continuously monitor and eliminate aberrant epithelial cells in their vicinity. In other words, it has become evident that epithelial cells possess immune cell-like functions. In fact, recent research has revealed that epithelial cells recognise the Major Histocompatibility Complex I (MHC-I) of aberrant cells as a mechanism for surveillance. This cellular defence mechanism of epithelial cells probably detects aberrant cells more promptly than the conventional immune response, making it a novel and primary biological defence. Furthermore, there is the potential for this new immune-like biological defence mechanism to establish innovative treatment for disease prevention, leading to increasing anticipation for its future medical applications. In this review, we aim to summarise the recognition and attack mechanisms of aberrant cells by epithelial cells in mammals, with a particular focus on the field of cancer. Additionally, we discuss the potential therapeutic applications of epithelial cell-based defence against cancer, including novel prophylactic treatment methods based on molecular mechanisms.

Morata G, Ripoll P (1975) Minutes — mutants of Drosophila autonomously affecting cell-division rate. Dev Biol 42(2):211–221. https://doi.org/10.1016/0012-1606(75)90330-9CrossRefPubMed

Van Neerven SM, Vermeulen L (2023) Cell competition in development, homeostasis and cancer. Nat Rev Mol Cell Biol 24(3):221–236. https://doi.org/10.1038/s41580-022-00538-yCrossRefPubMed

Maruyama T, Fujita Y (2017) Cell competition in mammals — novel homeostatic machinery for embryonic development and cancer prevention. Curr Opin Cell Biol 48:106–112. https://doi.org/10.1016/j.ceb.2017.06.007CrossRefPubMed

Maruyama T, Fujita Y (2022) Cell competition in vertebrates—a key machinery for tissue homeostasis. Curr Opin Genet Dev 72:15–21. https://doi.org/10.1016/j.gde.2021.09.006CrossRefPubMed

Hogan C, Dupré-Crochet S, Norman M et al (2009) Characterization of the interface between normal and transformed epithelial cells. Nat Cell Biol 11(4):460–467. https://doi.org/10.1038/ncb1853CrossRefPubMed

Kajita M, Hogan C, Harris AR et al (2010) Interaction with surrounding normal epithelial cells influences signalling pathways and behaviour of Src-transformed cells. J Cell Sci 123(2):171–180. https://doi.org/10.1242/jcs.057976CrossRefPubMed

Wagstaff L, Goschorska M, Kozyrska K et al (2016) Mechanical cell competition kills cells via induction of lethal p53 levels. Nat Commun 7. https://doi.org/10.1038/ncomms11373

Tamori Y, Bialucha CU, Tian AG et al (2010) Involvement of Lgl and Mahjong/VprBP in cell competition. Plos Biol 8 (7). https://doi.org/10.1371/journal.pbio.1000422

Chiba T, Ishihara E, Miyamura N, R. Narumi et al (2016) MDCK cells expressing constitutively active Yes-associated protein (YAP) undergo apical extrusion depending on neighboring cell status. Sci Rep 6. https://doi.org/10.1038/srep28383

10.

Moya IM, Castaldo SA, Van den Mooter L et al (2019) Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Science 366(6468):1029–1034. https://doi.org/10.1126/science.aaw9886CrossRefPubMed

11.

Alcolea MP, Jones PH (2015) Cell competition: winning out by losing notch. Cell Cycle 14(1):9–17. https://doi.org/10.4161/15384101.2014.988027CrossRefPubMedPubMedCentral

12.

Kon S, Ishibashi K, Katoh H et al (2017) Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes. Nat Cell Biol 19(5):530–541. https://doi.org/10.1038/ncb3509CrossRefPubMed

13.

Sasaki A, Nagatake T, Egami R et al (2018) Obesity suppresses cell-competition-mediated apical elimination of RasV12-transformed cells from epithelial tissues. Cell Rep 23(4):974–982. https://doi.org/10.1016/j.celrep.2018.03.104CrossRefPubMedPubMedCentral

14.

Ayukawa S, Kamoshita N, Nakayama J et al (2021) Epithelial cells remove precancerous cells by cell competition via MHC class I-LILRB3 interaction. Nat Immunol 22(11):1391–1402. https://doi.org/10.1038/s41590-021-01045-6CrossRefPubMed

15.

Takai T (2005) Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 115(4):433–440. https://doi.org/10.1111/j.1365-2567.2005.02177.xCrossRefPubMedPubMedCentral

16.

Yoshihama S, Vijayan S, Sidiq T, Kobayashi KS (2017) NLRC5/CITA: a key player in cancer immune surveillance. Trends in Cancer 3(1):28–38. https://doi.org/10.1016/j.trecan.2016.12.003CrossRefPubMedPubMedCentral

17.

Schwartz M, Portugez AS, Attia BZ et al (2020) Genomic retargeting of p53 and CTCF is associated with transcriptional changes during oncogenic HRas-induced transformation. Commun Biol 3 (1). https://doi.org/10.1038/s42003-020-01398-y

18.

Yoh KE, Regunath K, Guzman A et al (2016) Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells. Proc Natl Acad Sci USA 113(41):E6107–E6116. https://doi.org/10.1073/pnas.1613417113CrossRefPubMedPubMedCentral

19.

Franceschi RT, Xiao GZ (2003) Regulation of the osteoblast-specific transcription factor, runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 88(3):446–454. https://doi.org/10.1002/jcb.10369CrossRefPubMed

20.

Held W, Mariuzza RA (2008) Cis interactions of immunoreceptors with MHC and non-MHC ligands. Nat Rev Immunol 8(4):269–278. https://doi.org/10.1038/nri2278CrossRefPubMedPubMedCentral

21.

Shiroishi M, Kuroki K, Rasubala L et al (2006) Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci USA 103(44):16412–16417. https://doi.org/10.1073/pnas.0605228103CrossRefPubMedPubMedCentral

22.

Hill W, Zaragkoulias A, Salvador-Barbero B et al (2021) EPHA2-dependent outcompetition of KRASG12D mutant cells by wild-type neighbors in the adult pancreas. Curr Biol 31(12):2550–2560. https://doi.org/10.1016/j.cub.2021.03.094CrossRefPubMedPubMedCentral

23.

Porazinski S, de Navascués J, Yako Y et al (2016) EphA2 drives the segregation of Ras-transformed epithelial cells from normal neighbors. Curr Biol 26(23):3220–3229. https://doi.org/10.1016/j.cub.2016.09.037CrossRefPubMed

24.

Hill W, Hogan C (2019) Normal epithelial cells trigger EphA2-dependent RasV12 cell repulsion at the single cell level. Small GTPases 10(4):305–310. https://doi.org/10.1080/21541248.2017.1324940CrossRefPubMed

25.

Nakamoto M, Cheng HJ, Friedman GC et al (1996) Topographically specific effects of ELF-1 on retinal axon guidance in vitro and retinal axon mapping in vivo. Cell 86(5):755–766. https://doi.org/10.1016/s0092-8674(00)80150-6CrossRefPubMed

26.

Mori Y, Shiratsuchi N, Sato N et al (2022) Extracellular ATP facilitates cell extrusion from epithelial layers mediated by cell competition or apoptosis. Curr Biol 32(10):2144–2159. https://doi.org/10.1016/j.cub.2022.03.057CrossRefPubMed

27.

Ogawa M, Kawarazaki Y, Fujita Y et al (2021) FGF21 induced by the ASK1-p38 pathway promotes mechanical cell competition by attracting cells. Curr Biol 31 (5). https://doi.org/10.1016/j.cub.2020.11.052

28.

Gu YP, Forostyan T, Sabbadini R, Rosenblatt J (2011) Epithelial cell extrusion requires the sphingosine-1-phosphate receptor 2 pathway. J Cell Biol 193(4):667–676. https://doi.org/10.1083/jcb.201010075CrossRefPubMedPubMedCentral

29.

Yamamoto S, Yako Y, Fujioka Y et al (2016) A role of the sphingosine-1-phosphate (S1P)-S1P receptor 2 pathway in epithelial defense against cancer (EDAC). Mol Biol Cell 27(3):491–499. https://doi.org/10.1091/mbc.E15-03-0161CrossRefPubMedPubMedCentral

30.

Kajita M, Sugimura K, Ohoka A et al (2014) Filamin acts as a key regulator in epithelial defence against transformed cells. Nature Communication 5:4428. https://doi.org/10.1038/ncomms5428CrossRef

31.

Hamidouche Z, Fromigué O, Ringe J et al (2009) Priming integrin α5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc Natl Acad Sci USA 106(44):18587–18591. https://doi.org/10.1073/pnas.0812334106CrossRefPubMedPubMedCentral

32.

Wu SK, Gomez GA, Michael M et al (2014) Cortical F-actin stabilization generates apical-lateral patterns of junctional contractility that integrate cells into epithelia. Nat Cell Biol 16(2):167–178. https://doi.org/10.1038/ncb2900CrossRefPubMed

33.

Maruyama T, Sasaki A, Iijima S et al (2020) ZAK inhibitor PLX4720 promotes extrusion of transformed cells via cell competition. iScience 23 (7). https://doi.org/10.1016/j.isci.2020.101327

34.

Sato N, Yako Y, Maruyama T et al (2020) The COX-2/PGE₂ pathway suppresses apical elimination of RasV12-transformed cells from epithelia. Commun Biol 3 (1). https://doi.org/10.1038/s42003-020-0847-y

35.

Gallini S, Annusver K, Rahman NT et al (2023) Injury prevents Ras mutant cell expansion in mosaic skin. Nature 619:167–175. https://doi.org/10.1038/s41586-023-06198-yCrossRefPubMedPubMedCentral

36.

Greten FR, Grivennikov SI (2019) Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51(1):27–41. https://doi.org/10.1016/j.immuni.2019.06.025CrossRefPubMedPubMedCentral

37.

Pothapragada SP, Gupta P, Mukherjee S and Das T (2022) Matrix mechanics regulates epithelial defence against cancer by tuning dynamic localization of filamin. Nat Commun 13 (1). https://doi.org/10.1038/s41467-021-27896-z

38.

Madan E, Pelham CJ, Nagane M et al (2019) Flower isoforms promote competitive growth in cancer. Nature 572(7768):260–264. https://doi.org/10.1038/s41586-019-1429-3CrossRefPubMed

39.

Rhiner C, López-Gay JM, Soldini D et al (2010) Flower forms an extracellular code that reveals the fitness of a cell to its neighbors in Drosophila. Dev Cell 18(6):985–998. https://doi.org/10.1016/j.devcel.2010.05.010CrossRefPubMed

40.

de la Cova C, Abril M, Bellosta P et al (2004) Drosophila Myc regulates organ size by inducing cell competition. Cell 117(1):107–116. https://doi.org/10.1016/s0092-8674(04)00214-4CrossRefPubMed

41.

Moreno E, Basler K (2004) dMyc transforms cells into super-competitors. Cell 117(1):117–129. https://doi.org/10.1016/s0092-8674(04)00262-4CrossRefPubMed

42.

Ziosi M, Baena-López LA, Grifoni D et al (2010) dMyc functions downstream of Yorkie to promote the supercompetitive behavior of Hippo pathway mutant cells. PLoS Genet 6 (9). https://doi.org/10.1371/journal.pgen.1001140

43.

Rodrigues AB, Zoranovic T, Ayala-Camargo A et al (2012) Activated STAT regulates growth and induces competitive interactions independently of Myc, Yorkie. Wingless and ribosome biogenesis Development 139(21):4051–4061. https://doi.org/10.1242/dev.076760CrossRefPubMed

44.

Di Giacomo S, Sollazzo M, de Biase D et al (2017) Human cancer cells signal their competitive fitness through MYC activity. Sci Rep 7. https://doi.org/10.1038/s41598-017-13002-1

45.

Patel MS, Shah HS, Shrivastava N (2017) c-Myc-dependent cell competition in human cancer cells. J Cell Biochem 118(7):1782–1791. https://doi.org/10.1002/jcb.25846CrossRefPubMed

46.

Liu ZJ, Yee PP, Wei YJ et al (2019) Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis. J Cell Sci 132 (5). https://doi.org/10.1242/jcs.225714.

47.

Flanagan DJ, Pentinmikko N, Luopajärvi K et al (2021) NOTUM from Apc-mutant cells biases clonal competition to initiate cancer. Nature 594(7863):430–435. https://doi.org/10.1038/s41586-021-03525-zCrossRefPubMedPubMedCentral

48.

van Neerven SM, de Groot NE, Nijman LE et al (2021) Apc-mutant cells act as supercompetitors in intestinal tumour initiation. Nature 594(7863):436–441. https://doi.org/10.1038/s41586-021-03558-4CrossRefPubMed

49.

Kohashi K, Mori Y, Narumi R et al (2021) Sequential oncogenic mutations influence cell competition. Curr Biol 31(18):3984–3995. https://doi.org/10.1016/j.cub.2021.06.064CrossRefPubMed

50.

Kullander K, Klein R (2002) Mechanisms and functions of EPH and ephrin signalling. Nat Rev Mol Cell Biol 3(7):475–486. https://doi.org/10.1038/nrm856CrossRefPubMed

51.

Geng LL, Lam KSL, Xu AM (2020) The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat Rev Endocrinol 16(11):654–667. https://doi.org/10.1038/s41574-020-0386-0CrossRefPubMed

52.

Jhunjhunwala S, Hammer C, Delamarre L (2021) Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer 21(5):298–312. https://doi.org/10.1038/s41568-021-00339-zCrossRefPubMed

53.

Geng J, Raghavan M (2021) Conformational sensing of major histocompatibility complex (MHC) class I molecules by immune receptors and intracellular assembly factors. Curr Opin Immunol 70:67–74. https://doi.org/10.1016/j.coi.2021.03.014CrossRefPubMedPubMedCentral

54.

Aptsiauri NT, Cabrera A, Garcia-Lora MA et al (2007) MHC class I antigens and immune surveillance in transformed cells. Int Rev Cytol 256:139–189. https://doi.org/10.1016/s0074-7696(07)56005-5CrossRefPubMed

55.

Ljunggren HG, Karre K (1990) In search of the missing self — MHC molecules and NK cell recognition. Immunol Today 11(7):237–244. https://doi.org/10.1016/0167-5699(90)90097-sCrossRefPubMed

56.

Norris JL, Baldwin AS (1999) Oncogenic Ras enhances NF-κB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways. J Biol Chem 274(20):13841–13846. https://doi.org/10.1074/jbc.274.20.13841CrossRefPubMed

57.

Artis D (2008) Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8(6):411–420. https://doi.org/10.1038/nri2316CrossRefPubMed

58.

Bastounis EE, Serrano-Alcalde F, Radhakrishnan P et al (2021) Mechanical competition triggered by innate immune signaling drives the collective extrusion of bacterially infected epithelial cells. Dev Cell 56(4):443–460. https://doi.org/10.1016/j.devcel.2021.01.012CrossRefPubMedPubMedCentral

59.

Gobin SJP, Keijsers V, van Zutphen M et al (1998) The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor κB. J Immunol 161(5):2276–2283. https://doi.org/10.4049/jimmunol.161.5.2276CrossRefPubMed

60.

Guo XC, Liu TX, Shi HF et al (2015) Respiratory syncytial virus infection upregulates NLRC5 and major histocompatibility complex class I expression through RIG-I induction in airway epithelial cells. J Virol 89(15):7636–7645. https://doi.org/10.1128/jvi.00349-15CrossRefPubMedPubMedCentral

61.

Herzer K, Falk CS, Encke J et al (2003) Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J Virol 77(15):8299–8309. https://doi.org/10.1128/jvi.77.15.8299-8309.2003CrossRefPubMedPubMedCentral

Titel: Epithelial recognition and elimination against aberrant cells
verfasst von: Shiyu Ayukawa
Nagisa Kamoshita
Takeshi Maruyama
Publikationsdatum: 27.02.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Seminars in Immunopathology / Ausgabe 4-6/2024
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-024-01001-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Epithelial recognition and elimination against aberrant cells

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4-6/2024

Physiological and immunological barriers in the lung

The overlooked bacterial pandemic

Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity

Causes and costs of global COVID-19 vaccine inequity

The role of vaccines in the COVID-19 pandemic: what have we learned?

Correction: Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Innere Medizin